Name
Medexus Pharma, Inc
What We Do
Medexus Pharmaceuticals, Inc. is a leading innovative specialty pharmaceutical company, introducing GRAFAPEX (treosulfan) for Injection which is the first and only FDA-approved conditioning regimen, that is indicated for use in combination with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation (alloHSCT) in adult and pediatric patients one year of age and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Founded
2018
Website
Address
29 N. Wacker Drive Ste 704
Chicago, IL 60606
United States
Chicago, IL 60606
United States